Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Murray

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
International Immunology|November 1, 1992
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cellsM G Masucci, Q J Zhang, R Gavioli, et al.
Journal of Medicinal Chemistry|April 28, 1995
In vitro muscarinic activity of spiromuscarones and related analogsE S Wu, R C Griffith, J T Loch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2011
Prevalence of nasal methicillin-resistant Staphylococcus aureus colonization in healthcare workers in a Western Australian acute care hospitalP E B Verwer, J O Robinson, G W Coombs, et al.
International Journal of Immunopharmacology|January 1, 1990
Effect of oxamisole on immune parameters of mice infected with murine hepatitisR P Warren, R W Sidwell, J H Huffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemiaG C Palmer, E C Cregan, A R Borrelli, et al.
Epilepsy Research|June 1, 1992
Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemideG C Palmer, R J Murray, T C Wilson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2010
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control studyM C Wehrhahn, J O Robinson, J C Pearson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
[S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic propertiesG C Palmer, R J Murray, C L Cramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
-(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemiaE F Cregan, J Peeling, D Corbett, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
International Immunology|November 1, 1992
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cellsM G Masucci, Q J Zhang, R Gavioli, et al.
Journal of Medicinal Chemistry|April 28, 1995
In vitro muscarinic activity of spiromuscarones and related analogsE S Wu, R C Griffith, J T Loch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 13, 2011
Prevalence of nasal methicillin-resistant Staphylococcus aureus colonization in healthcare workers in a Western Australian acute care hospitalP E B Verwer, J O Robinson, G W Coombs, et al.
International Journal of Immunopharmacology|January 1, 1990
Effect of oxamisole on immune parameters of mice infected with murine hepatitisR P Warren, R W Sidwell, J H Huffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1995
Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemiaG C Palmer, E C Cregan, A R Borrelli, et al.
Epilepsy Research|June 1, 1992
Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemideG C Palmer, R J Murray, T C Wilson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2010
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control studyM C Wehrhahn, J O Robinson, J C Pearson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
[S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic propertiesG C Palmer, R J Murray, C L Cramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
-(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemiaE F Cregan, J Peeling, D Corbett, et al.
Pageof 7